Chutima MatayatsukChung Yung J. LeeRuchaneekorn W. KalpravidhPornpan SirankaprachaPrapin WilairatSuthat FucharoenBarry HalliwellMahidol UniversityYong Loo Lin School of MedicineThe Institute of Science and Technology for Research and Development, Mahidol University2018-08-242018-08-242007-12-15Free Radical Biology and Medicine. Vol.43, No.12 (2007), 1649-1655089158492-s2.0-36248946663https://repository.li.mahidol.ac.th/handle/20.500.14594/24061This study was aimed at investigating oxidative stress in thalassemic patients by measurement of the oxidative damage biomarker, F2-isoprostanes (F2-IsoPs), using gas chromatography-mass spectrometry. The results showed that the mean value of urinary F2-IsoPs, normalized with creatinine, in the thalassemic group was significantly higher than that from healthy subjects (3.38 ± 2.15 ng/mg creatinine vs 0.86 ± 0.55 ng/mg creatinine, respectively), and the mean value of plasma total F2-IsoPs in the thalassemic group was also significantly higher than that from healthy subjects (0.39 ± 0.15 ng/ml vs 0.18 ± 0.03 ng/ml, respectively). Serum ferritin, erythrocyte superoxide dismutase (SOD), glutathione peroxidase, glutathione, and TBARS levels after treatment of erythrocytes with H2O2were also investigated, and serum ferritin and erythrocyte SOD levels were significantly higher in thalassemic patients. Our findings are consistent with oxidative stress in thalassemia patients. © 2007 Elsevier Inc. All rights reserved.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyMedicineElevated F<inf>2</inf>-isoprostanes in thalassemic patientsArticleSCOPUS10.1016/j.freeradbiomed.2007.08.026